Active substance
Carbomer
- SFDA 2
- NHS prices 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Artelac Night Time Gel | 2 mg/g | Gel · Ophthalmic use | 1 Tube | SAR 30.10 | Generic · OTC | Dr. Gerhard Mann Chem. - Pharma. Fabrik GmbH | Invalid · Not Marketed |
| VISCOTEARS OPTH.GEL | 2 | eye gel · Topical | 1 Tube | SAR 17.40 | Generic · OTC | NOVARTIS | Withdrawn by MAH · Not Marketed |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Carbomer '980' 0.2% eye drops | £2.80 | 10 gram | 1 Oct 2026 |
| NHS Drug Tariff | Carbomer '980' 0.2% eye drops 0.6ml unit dose preservative free | £5.42 | 30 unit dose | 1 Oct 2026 |
| NHS Drug Tariff | Carbomer 974P 0.25% eye gel | £4.50 | 10 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Carbomer
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.